Introduction equilibrium with a complex in which the receptor is in a metastable, nearly mature state competent to bind Geldanamycin, and its closely related analogs herbihormone (Smith et al., 1995; Dittmar et al., 1996) . This mycin and macbecin, are naturally occurring antitumor nearly mature complex lacks Hsp70, p60, and Hip, but antibiotics (DeBoer et al., 1970; Omura et al., 1979 ; Ono contains two new proteins, p23 and one of the three et al., 1982) . In the National Cancer Institute's (NCI) in large immunophilins, FKBP52, FKBP54, or CyP40 (Smith vitro screen for antitumor agents, geldanamycin has et al., 1995; Dittmar et al., 1996) . Upon hormone binding, shown potent activity, achieving 50% growth inhibition the receptor is released as an active transcription factor (GI50) at concentrations as low as 13 nM against the (Smith et al., 1995; Dittmar et al., 1996) . Treatment with most responsive cell lines, with a mean GI50 of 180 nM geldanamycin appears to block the conversion to the against all 60 of the tumor cell lines (Supko et al., 1995) .
nearly mature complex, preventing hormone binding Geldanamycin is active in mouse tumor models as well and activation, and results in the degradation of the (Sasaki et al., 1979; Ono et al., 1982) , and it has been hormone receptor (Whitesell and Cook, 1996) . selected for preclinical development as an antitumor
The requirement for Hsp90 in the activation of the agent by the NCI (Supko et al., 1995) .
aforementioned protein kinases has been demonstrated both genetically (Xu and Lindquist, 1993; Aligue et al., 1994; Nathan and Lindquist, 1995) and biochemically
These authors contributed equally to this work. (A) The three structural domains of Hsp90, identified by proteolytic digestion, are indicated, together with their percent identity in the E. coli homolog. The oligomerization activity at the C-terminal portion has been described (Wearsch and Nicchitta, 1996) . The digestion of residues 1-9 is consistent with this region being absent from most Hsp90 sequences except mammalian ones. To identify the geldanamycin-binding domain, the purified structural domains, at 1 M, were incubated with 2.0 M geldanamycin (GIBCO-BRL) each; the free drug was then separated on a gel filtration column, monitoring absorption at 280 nm, and the protein peaks (the C-terminal domain absorbed weakly at 280 nm for lack of tryptophans) were analyzed for the presence of geldanamycin by reverse-phase HPLC, with monitoring at 310 nm. The gel filtration protein peak of the N-terminal domain was the only one that contained geldanamycin; the molar ratio was determined to be approximately 1:1 based on UV absorption. The composition of the two secondary geldanamycin peaks observed in the reversed phase chromatography is not clear, but they could also be produced by the addition of dithiothreitol in the absence of protein.
Geldanamycin is abbreviated as GDM.
(B) Stereo view of the geldanamycin 2Fo-Fc electron density before any geldanamycin atoms were built into the Hsp90 model. The map was calculated at 2.0 Å and contoured at 1.0 sigma; also shown is the refined geldanamycin model in a ball-and-stick representation.
( Hartson and Matts, 1994; Chavany et al., 1996 ; Stepaas a result, luciferase is retained in the Hsp90 complex in an unfolded, degradation-sensitive state (Schneider et nova et al., 1996) . This reaction is not as well understood, but it appears to involve a subset of the molecules found al. , 1996) . This shifts the balance from refolding to the proteolytic degradation of the protein (Schneider et al. , in the complexes with hormone receptors, as well as a protein kinase-specific cofactor, p50
Cdc37 (Whitelaw et 1996) . Such a mechanism might also explain how, under nonstress conditions, geldanamycin and its homologs al., 1991; Stancato et al., 1993; Cutforth and Rubin, 1994; Stepanova et al., 1996) . For some of these kinases, such cause the degradation of the signaling molecules.
To obtain insights into the function of Hsp90 in these as Raf-1, Hsp90 association is a prerequisite for their trafficking to the plasma membrane (Schulte et al., 1995) ; conformational maturation/refolding processes and its inhibition by geldanamycin, we identified the geldanafor others, the mechanism of Hsp90-mediated activation is not yet understood. Again, geldanamycin interferes mycin-binding domain of Hsp90 (henceforth Hsp90-GBD), and we determined the crystal structures of this with Hsp90 function and induces the rapid degradation of these kinases by the proteosome system (Murakami domain and of its complex with geldanamycin. et al., 1994; Schulte et al., 1995; Schneider et al., 1996; Stepanova et al., 1996) .
Results and Discussion In addition to its role in the conformational maturation of signal transduction molecules, the eukaryotic Hsp90
Isolation of the Geldanamycin-Binding Domain of Hsp90 system participates in the refolding of certain thermally denatured polypeptides during the recovery of cells
To facilitate the structural study of the geldanamycinHsp90 interaction, we first used proteolytic digestion from heat stress (Borkovich et al., 1989) . Using firefly luciferase as a model substrate, it was demonstrated and determined that the bovine Hsp90 contains three structural domains ( Figure 1A ): an N-terminal domain of that Hsp90 cooperates in this process with Hsp70, Hsp40 (a DnaJ homolog), p60, Hip, and p23 (Schuapproximately 25 kDa, a middle domain of approximately  35 kDa, and a C-terminal domain of approximately 10  macher et Schneider et al., 1996) . Thus, the Hsp90 complexes formed with the thermally denatured kDa. We then assayed the three corresponding recombinant domains of human Hsp90 for geldanamycin binding polypeptide resemble those of hormone receptors and protein kinases. Geldanamycin inhibits the Hsp90-mediusing gel filtration chromatography to remove excess drug and reverse-phase HPLC to detect the bound drug, ated refolding of luciferase, both in vitro and in vivo, and, ϭ Ͻ⌺ P(␣) exp(i␣) / ⌺ P(␣)Ͼ, where P(␣) is the probability distribution for the phase ␣. Atoms modeled discounts hydrogen atoms. R ϭ ⌺ԽF p Ϫ FcalcԽ / ⌺Fp, where Fcalc is the calculated protein structure factor from the atomic model; Rfree is the R factor calculated using 10% of the reflection data chosen randomly and omitted from the refinement process, whereas Rcryst is calculated with the remaining data used in the refinement. rms. bond lengths and angles are the deviations from ideal values; the rms deviation in B factors is calculated between covalently bonded atoms. and determined that the N-terminal domain, which has hydrophobic core of the structure and results in a prothe highest sequence conservation among the three nounced pocket, about 15 Å deep ( Figures 2B-2D ). The domains, binds geldanamycin at an approximately one pocket has the ␤ sheet as its base and three helices molar ratio ( Figure 1A) . and a loop as its walls, and contains residues highly In crystallization experiments, the geldanamycinconserved across species (Figure 3 ). The helical face of binding domain of human Hsp90 (Hsp90-GBD, residues the sandwich also has a surface groove that leads into 9-236) produced two distinct crystal forms in which the the pocket. structure differs by a local conformational change. The
In the complex, the 560 Da geldanamycin adopts a geldanamycin-Hsp90-GBD complex crystallized in only compact conformation and binds inside the pocket, fillone of the two forms. The two apo-Hsp90-GBD strucing all but its deepest portion (Figures 2A-2E ). The tures have been determined at 1.65 and 2.2 Å resolution, benzoquinone group of geldanamycin binds near the respectively, and the structure of the geldanamycin entrance of the pocket, whereas the ansamycin ring, complex at 1.9 Å resolution (Table 1, Figure 1B ).
having dimensions similar to those of a five amino acid polypeptide in a turn conformation, inserts into the pocket. There is extensive, though not complete, surOverall Structure of the face complementarity between geldanamycin and the Geldanamycin-Hsp90-GBD Complex pocket, and this allows for a high density of van der The Hsp90-GBD has nine helices and an antiparallel ␤ Waals contacts. Although hydrogen bond contacts are sheet of eight strands that together fold into an ␣ϩ␤ fewer, there being only five of them, one pair from the sandwich (Figures 2A-2D ). One face of the ␤ sheet is geldanamycin carbamate group ( Figure 2E ) can be reahydrophobic and packs against a layer of five helices; sonably described as one of the most important intermofour of these helices (H1, H2, H4, and H9) pack flatly lecular interactions in the complex. against the ␤ sheet, with their axes parallel to the ␤ The entrance and width of the pocket are likely regustrands, while H7 packs against the ␤ sheet at a steeper, lated by a conformational change, as evidenced by almost perpendicular angle. The structure has a second structural and positional changes in three helices and layer of helices that pack on the first layer (H5 and H6), a loop in the two different apo-Hsp90-GBD crystal forms and two smaller helices (H3 and H8) at the periphery of ( Table 1) . One of the conformations, which is essenthe sandwich (Figures 2A-2D ). It is noteworthy that four tially identical to that observed in the crystals of the of the nine helices are of the 3 10 type and comprise geldanamycin-Hsp90-GBD complex, has a wide enough 11.2% of the amino acids, which is significantly higher entrance to allow geldanamycin binding. The other conthan the 3.4% average in the protein database (Barlow formation has a narrower entrance, and it would be and Thornton, 1988). At its center, the helical face of the sandwich has a wide opening that extends into the incompatible with geldanamycin binding. Architecture and Properties of the at its deepest portion (Asp93 and Thr184 from the ␤ sheet).
Geldanamycin-Binding Pocket
The pocket can be described as a flat-bottomed cone:
The Hsp90-GBD domain is highly conserved across species, with 43% of its residues identical in the Escheit is about 15 Å deep, 12 Å in diameter near its entrance, 8 Å midway down, and wide enough at the bottom to richia coli Hsp90 homolog. The structure reveals that the conserved residues are not distributed homogehold three water molecules ( Figure 4A ). The bottom of the pocket is formed by the central portion of the antiparneously on the structure, but instead show a striking tendency to cluster in and around the pocket, with 82% allel ␤ sheet (strands S3, S4, and S7), and the walls by the H2, H4, and H7 helices and the L1 loop (Figure 3) . of the residues lining the interior of the pocket being invariant from E. coli to humans (Figures 3 and 4B ). This The pocket is deepest by the H7 helix, which packs at an almost perpendicular angle to the ␤ sheet bottom, identifies the pocket as holding the key to understanding the function of this domain. Of particular interest is and is shallowest by the L1 loop. The pocket is of mixed hydrophobic and polar character, with roughly half of Asp93, because it is at the pocket bottom in an otherwise mostly hydrophobic environment, and because it is conthe 17 amino acids lining its interior being hydrophobic, a quarter polar, and a quarter charged (these residues served in all known Hsp90 homologs from 35 species. Supporting a functional significance for this pocket are Leu48, Asn51, Asp54, Ala55, Lys58, Ile91, Asp93, Ile96, Gly97, Met98, Asn106, Leu107, Lys112, Gly135, are mutations in the yeast homolog of Hsp90 (Hsp82) that result in either temperature-sensitive or reduced Phe138, Val150, Thr184, and Val186; Figure 3 ). Although the pocket becomes increasingly hydrophobic toward activity phenotypes (Bohen and Yamamoto, 1993; Sullivan and Toft, 1993; Kimura et al., 1994; Nathan and the bottom, it retains one charged and one polar residue Lindquist, 1995), as well as a mutation in the Drosophila These mutations map either in the pocket (Ala55Val, Gly95Ser, Gly183Asp) or in the immediate vicinity of the Hsp90 (Hsp83) that impairs signaling by the Sevenless receptor tyrosine kinase (Cutforth and Rubin, 1994) .
pocket (Thr36Asn, Ser50Leu, Ala111Thr, Thr115Ile), and (A) A thin slice of the Hsp90-GBD molecular surface, depicted as a white net, stressing the pocket dimensions. Red indicates surface portions with a negative electrostatic potential, and blue those with a positive potential. The pocket is mostly polar at its entrance (Lys58 and Lys112 are shown), and it becomes predominantly hydrophobic near the bottom, except for Asp93. The approximate locations of the ␤ sheet and of the H7 helix are indicated; the H2 helix would be approximately above the plane of the figure, whereas the H4 helix would be below. This image was prepared with the program GRASP (Nicholls et al., 1991) . (B) Yellow highlights the positions of residues invariant in the E. coli Hsp90 homolog; magenta highlights residues, shown in space filling representation, where either temperature-sensitive or inactivating mutations map.
(C) Surface representation indicating the pocket and groove. Also indicated, in yellow, are several patches of exposed hydrophobic amino acids in the vicinity of the pocket and groove. These hydrophobic residues are: Phe213 to the right of the groove in this view; Ala117, Ala121, Ala124, Ala126, Met130, and Phe134 to the left of the groove; and Phe20, Ile104, Ala111, and Ile112 to the left of the pocket (prepared with the program GRASP).
change is a displacement of the L2 loop into the pocket by more than 9 Å (C␣-C␣ distance), whereupon the L2 loop replaces the H4 helix as one of the pocket walls. The motion of the L2 loop is facilitated by portions of the H4 and H5 helices undergoing helix-to-coil and coilto-helix transitions, respectively (Figures 3 and 5) . The H4 and H5 helices also are displaced, by up to 6 Å . The functional consequence of this conformational change is that the L2 loop acts as a gate that constricts the pocket entrance from a width of 12 Å to 8 Å ( Figure 5 ). These two alternate conformations have clear electron density in their respective crystal forms and are associated with well-packed side chain arrangements (Figure 3) . It is conceivable that this conformational change in vitro may mimic a process that occurs in vivo and may be involved in the regulation or functioning of the pocket. Supporting an in vivo role for the closed conformation is the Ala111Thr mutation on the L2 loop that results in a temperature-sensitive phenotype in yeast (Kimura et al., 1994) . This mutation would disrupt the closed conformation structure where Ala111 is fully buried and participates in the hydrophobic packing of the loop, but not the open conformation structure where Ala111 is fully solvent exposed with no apparent struc- consists of a planar amide and three carbon-carbon double bonds (two of them arranged in a 1,3 diene), and (2) of its sixteen backbone atoms, nine carry nonhydrothe structure suggests that most of these mutations gen substituents: a carbonyl, a carbamate (-OC(O)NH 2 ), would disrupt the structural integrity of the pocket (Figa hydroxyl, two methoxy, and four methyl groups ( Figure  ures 3 and 4B) . 2E). Leading to the pocket, there is a surface groove Hsp90-bound geldanamycin is highly compact and formed by the H6 and H9 helices on the sides, and the internally well packed (overall dimensions of about 9 ϫ H2 helix at its bottom ( Figure 4C ). Its shape is not as 9 ϫ 9 Å ). Its ansa ring is folded over the benzoquinone, pronounced as the pocket, being shallower (about 7-8 forming a C-clamp-like structure, with the benzoquinone Å ), broader (about 15 Å ), and mostly polar. This groove forming the top of the (C) and the ansa ring forming the is conserved, although not as well as the pocket, with stem and bottom of the (C) ( Figure 6A ). Two of the methyl 73% of the residues lining its concave surface identical groups from the ansa ring are centrally positioned to in the E. coli homolog (these residues are Asn40, Glu42, maximize intramolecular van der Waals contacts: the Ile43, Arg46, Glu47, Ser50, Ser129, Gln133, His210, C25 methyl group from the tip of the ansa ring packs Ser211, and Ile214; Figure 3 ). Since many of these resiwith the benzoquinone, thus bridging the top and botdues are polar or charged, without any significant roles tom halves of the (C), and the C28 methyl group packs in the structural integrity of this domain, their conservawith the diene carbon atoms, bridging the two sides of tion suggests that the groove may participate in intermothe ansa ring ( Figure 6A ). lecular interactions important for Hsp90 function.
This compact conformation differs from those observed with free geldanamycin (Rinehart and Shield, Conformational Change Alters the Size 1976) or herbimycin (Furusaki et al., 1980) , which crystaland Accessibility of the Pocket lize from organic solvents in significantly more open, An approximately 35 amino acid region of the Hsp90-extended conformations. The differences are likely due, GBD structure, consisting of the H4-L2-H5-H6 secondary in part, to the loss of coplanarity between the amide structure elements (residues 100-134), has two different group and the benzoquinone in Hsp90-bound geldanaconformations in the two different Apo-Hsp90-GBD mycin, as well as to the differences in the crystallization crystal forms (Table 1, Figures 3 and 5) . We have termed solvents. these the "open" and "closed" conformations because they result in different pocket size and accessibility, with only the open conformation being compatible with
Geldanamycin-Hsp90 Contacts
The tip of the geldanamycin ansa ring (bottom of [C]), geldanamycin binding.
At the center of the open-to-closed conformational which has the carbamate, C23 methoxy, and C25 and Figure 2A , and Hsp90 residues that make up the pocket are colored magenta. Hydrogen bonds are indicated by green dotted lines, and the water molecule that bridges the geldanamycin carbamate group with Asp93 is shown as a red sphere.
(C) Geldanamycin, in space-filling representation, adopts a structure that is, overall, complementary to the pocket, shown as a blue molecular surface net. Although the fit is extensive, there remains a buried cavity at the interface with three trapped water molecules in it (colored magenta), while a fourth water molecule hydrogen bonds with the carbamate group and Asp93. The reduced complementarity near the pocket entrance is evident as gaps between the geldanamycin atoms and the Hsp90-GBD surface. Orientation is similar to that of Figure 4A .
C26 methyl group substituents, binds near the bottom mostly hydrophobic environment. The carbamate amino group makes a hydrogen bond to one of the Asp93 of the Hsp90 pocket and makes a high density of van der Waals contacts, whereas the benzoquinone (top of side chain oxygen atoms, and its carbonyl oxygen atom makes a water-bridged hydrogen bond with the other [C] ) is positioned near the entrance of the pocket and makes only a few contacts (Figures 6A and 6B ). There Asp93 side chain oxygen atom ( Figures 6A and 6B ). The Asp93 side chain, which has an identical conformation is extensive surface complementarity between the compact geldanamycin structure and the pocket, as attested in the Apo-Hsp90 structures, also hydrogen bonds to the Ser52 OH and the backbone amide of residue 95. by the fact that a remarkable 85% of the surface area of geldanamycin is buried in the complex (609 Å 2 out of This hydrogen bond network is buried about 10 Å away from the nearest solvent surface, and the low dielectric 719 Å 2 ). The most critical portion of the interface is likely to constant of this environment would significantly increase the coulombic attraction due to the partial be a hydrogen bond network between the geldanamycin carbamate group and the Asp93 side chain from Hsp90, charges. The importance of this hydrogen bond network is supported by structure activity studies demonstrating which are buried at the pocket bottom in an otherwise that the removal of the carbamate group, or the attach- (Schnur et al., 1995a) . The structure supports this hypothesis, as this position is highly solvent exposed in the ment of additional atoms to it, completely abolished geldanamycin activity (Schnur et al., 1995b) . complex and is a poor candidate for additional Hsp90 contacts. At the tip of the ansa ring, the carbamate group contact is flanked by the C23 methoxy and C25 and C26
Overall, however, most modifications decreased or eliminated activity (Schnur et al., 1995a (Schnur et al., , 1995b . The methyl groups making high density van der Waals contacts with the bottom and sides of the pocket (Figures maintenance of the carbamate group and of the closed, cyclic nature of the ansa ring proved necessary for activ-6A and 6B). Although the surface complementarity at the pocket bottom is extensive, there remains a buried ity (Schnur et al., 1995b) , consistent with the extended hydrogen bond network that the carbamate group cavity filled with three water molecules near the C23 methoxy and the carbamate groups ( Figure 6C ). It is makes and with the importance of a closed cyclic ring in limiting conformational flexibility, respectively. Modificonceivable that the cellular substrates of Hsp90 can fill this cavity as well. Modifications to this portion of cations at other positions either had little effect or reduced the activity of geldanamycin in line with space geldanamycin, for example by adding to the C23 position a group of 4-6 nonhydrogen atoms, could increase considerations revealed by the crystal structure. For example, additions of small groups to the amide nitrogen the steric and hydrogen bond complementarity and may yield derivatives with increased affinity for Hsp90.
and to the C19 position of the benzoquinone, which are juxtaposed in a partially solvent-exposed region of the Halfway between the pocket bottom and the surface, the widening of the pocket causes a decrease in the complex, were tolerated (Schnur et al., 1995a (Schnur et al., , 1995b , whereas bulky substituents at these positions reduced complementarity and contact density, although the fit is still adequate to exclude bulk solvent ( Figure 6C ). In or eliminated activity (Schnur et al., 1995b) . Our crystal structure suggests modifications, such as this region, the diene and the C27 methoxy groups make van der Waals contacts, and the O5 hydroxyl group those at the C23 methoxy and C22 methyl groups discussed earlier, that could improve the steric and hydromakes a hydrogen bond contact with Lys58 ( Figures 6A  and 6B ). As we get closer to the surface, the contact gen bond complementarity between geldanamycin and Hsp90 and could thus provide analogs with increased density decreases further. In this region, the C28 methyl group appears to be in an overall unfavorable environHsp90 affinity (a total synthesis of geldanamycin has recently been reported [Miller, 1995] ). In addition, by ment, being within van der Waals contact distance to a backbone carbonyl oxygen atom and a partially buried identifying which modifications are compatible with Hsp90 binding, the structure should also help with the water molecule ( Figures 6A and 6B) . The loose fit in this region, both sterically and electrostatically, points to a improvement of geldanamycin's low plasma half-life (Supko et al., 1995) and other pharmacological properpotential for a significant improvement of the affinity of geldanamycin for Hsp90 ( Figure 6C) . ties as well. At the pocket entrance, the carbonyl oxygen atom of the ansa ring makes a hydrogen bond to a backbone Implications for Understanding amide (Phe138) at the N-terminal portion of the H7 helix Hsp90 Function (Figures 6A and 6B) . The benzoquinone, which is at the The pocket is best considered as a substrate-binding pocket entrance with one face solvent-exposed, makes site, for there are extensive similarities between the only a few contacts, and these are primarily solventpocket and a typical enzyme active site, though no covaexposed hydrogen bonds made to long lysine chains: lent chemistry is implied by the similarities. We note that: one of the benzoquinone oxygen atoms hydrogen bonds (1) the pocket has adequate space and hydrophobic with Lys112, and the C29 methoxy group oxygen atom content, and is adequately shielded from bulk solvent makes a long-distance (3.5 Å ) hydrogen bond with to tightly bind substrates of a few hundred daltons; (2) Lys58.
there is a nonuniform electrostatic distribution resulting from an aspartic acid at the otherwise hydrophobic botGeldanamycin Derivatives tom of the pocket; (3) the shape and size of the pocket Among the naturally occurring homologs, geldanamycin entrance is likely to be regulated by a conformational is the most potent. Compared to herbimycin, for examchange; (4) the geldanamycin-binding domain of Hsp90 ple, geldanamycin is more potent by a factor of about is the best conserved among its three structural dofour in achieving a 50% reduction (IC50) of erbB-2 kinase mains, and within this domain, the conserved residues activity in human SKBr3 breast cancer cells (Miller et cluster in and around the pocket; (5) mutations that al., 1994). The structure suggests that this may be due inactivate Hsp90 map in and around the pocket; and, to the hydrogen bond that the C29 methoxy oxygen finally, (6) the geldanamycin inhibitor of Hsp90 function atom of geldanamycin makes with Lys58, because herbinds inside this pocket. bimycin does not have the C29 methoxy group.
Assuming that the Hsp90 pocket is a substrate binding Among the published synthetic derivatives (Schnur et site, it can then directly follow that its substrate is the al., 1995a, 1995b), the highest potency, reflecting an protein, or more precisely, a segment of the protein, improvement in the IC 50 of a factor of 4-5, was achieved whose conformational maturation/refolding is mediated by an amino group substitution at the C17 position of by the Hsp90 chaperone system. This pocket-polypepthe benzoquinone (Schnur et al., 1995a) . It was proposed tide association is likely to occur as a late step in the that this and several related substitutions at the C17 reaction pathway because Hsp70, which is present in position improved cellular activity indirectly, by stabilizing the quinone form over the reduced hydroquinone all of the early Hsp90 complexes Smith et al., 1995; Dittmar et al., 1996; Johnson et al., 1996) , can bind unfolded proteins (Flynn et al., 1991; Zhu et al., 1996) and is thus the likely initial recruiter of the unfolded polypeptide to the Hsp90 complex. That a polypeptide portion is the substrate for the pocket is supported by the ability of the endoplasmic reticulum homolog, GP96, to associate with a specific viral peptide, though it is not yet known with which domain of GP96 this peptide is associated (Nieland et al., 1996) . Further support is provided by the general similarities between the geldanamycin ansa ring and a peptide. A five amino acid polypeptide in a turn conformation could closely trace the geldanamycin ansa ring backbone, with its amino acid side chains broadly corresponding to the carbamate, methyl, and methoxy groups of geldanamycin (Figure 7) . Furthermore, and intended only as an example, steric and hydrogen bond complementarity considerations suggest that a tryptophan amino acid donor amino acids, could also satisfy the hydrogen bond potential of Asp93, although they may not have as good of a fit as a tryptophan in the buried cavity.
is possible; however, we note that: (1) it is unlikely that It is conceivable that the pocket binds a family of such an unusual pocket would have evolved to bind a related polypeptide sequences, and this could explain protein cofactor; (2) p23 and the pocket could have the conservation of the pocket residues, because a large coevolved resulting in far lesser sequence conservation family of peptide sequences, in contrast to a single seat the pocket; and (3) E. coli and lower eukaryotes do quence, could not coevolve with amino acid changes not seem to have p23, at least not one that is as conin the pocket. This has precedence in the Hsp70 chaperserved as the Hsp90-GBD. one, which has a peptide-binding channel highly conOn the other hand, the isolation of complexes of heatserved between E. coli and humans (Zhu et al., 1996) , denatured luciferase and of Raf with Hsp90 in the presand binds unfolded proteins by interacting with sevenence of geldanamycin (Schneider et al., 1996) at first residue segments, having exposed hydrophobic amino appears to be inconsistent with the pocket binding these acids at their central positions (Flynn et al., 1991; Zhu substrates. It is conceivable, however, that Hsp90 conet al., 1996) . tains additional polypeptide-interacting sites that are A model in which the polypeptide substrate binds in not blocked by geldanamycin and that act at an earlier the pocket along the reaction pathway would be supstage. These additional sites can be either within its ported by the observation that geldanamycin causes the geldanamycin-binding domain (for example, the condissociation of the v-src-Hsp90 complex in transformed served surface groove) or in the rest of the 732 residue cells . Also consistent are observaprotein. Alternatively, the observed association of geltions from the in vitro conformational maturation of the danamycin-bound Hsp90 with the protein substrate may steroid receptors. In this reaction, a transient complex be indirect, since these complexes contain several other of the receptor that includes Hsp90, Hsp70, and several protein cofactors, such as Hsp70, which may contribute other cofactors is in equilibrium with the hormoneto polypeptide binding (Bose et al., 1996 ; Duina et al., responsive state of the receptor, which is bound to 1996; Schneider et al., 1996) . In Hsp90, p23, and an immunophilin (Smith et al., 1995;  any case, geldanamycin blocks the refolding of the heat- Dittmar et al., 1996; Nair et al., 1996) . Geldanamycin denatured Raf and luciferase substrates, and this ultiblocks the formation of the latter complex, consistent mately results in their degradation (Schneider et al., with receptor-pocket interactions being required to ei-1996) . ther arrive at or to maintain the hormone-responsive
The crystal structure of the Hsp90-GBD reveals a state of the receptor (Smith et al., 1995; Nair et al., pocket whose properties indicate that it is a likely bind-1996). In principle, the interruption of this reaction by ing site for the polypeptide substrate. That geldanageldanamycin can be interpreted in other ways, for exmycin, by binding in this pocket, inhibits the Hsp90-ample, to mean that geldanamycin directly competes with p23 (Smith et al., 1995) binding to the pocket. This catalyzed conformational reaction both in vitro and in residues 11-16 were visible and modeled, whereas two solventvivo strongly argues that the pocket-substrate interac- antitumor activity.
helices are in both crystal forms. In addition to magnesium and geldanamycin, the growth of the P2 1 form can be induced by acidic Experimental Procedures pH as well.
Identification of the Geldanamycin-Binding

